Clinical Trials -Breast Cancer

Phase 1 (phase I) trials study whether a new treatment is safe to use over a range of doses. The treatment may be given to people with different types of cancers.

A phase 1 trial is mainly a drug safety study.

Phase 2 (phase II) trials study how well a treatment works for a certain cancer, such as breast cancer. These trials may include between 25 and 100 people.

After a drug (or other therapy) is found to be effective in treating breast cancer in a phase 2 trials, a phase 3 trial will study it further.

Phase 3 (phase III) trials study how well a new treatment (including surgical procedures) works compared to the standard treatment (standard of care).

Phase 4 (phase IV) trials study the long-term side effects of treatments or answer new questions about the treatment.

  • Phases of Trails
  • Cohort and Case Studies
  • Randomization
  • Screening and Prevention trials
  • Pilot Studies and Feasibility Studies

Related Conference of Clinical Trials -Breast Cancer

June 11-12, 2024

31st Global Nursing and Health Care Conference

Amsterdam, Netherlands
June 20-21, 2024

55th World Nursing and Healthcare Conference

Dublin, Ireland
June 27-28, 2024

61st World Nursing Conference

London, UK
July 18-19, 2024

31st Global Nursing and Healthcare Congress

Paris, France
August 08-09, 2024

43rd World Nursing and Healthcare Conference

London, UK
September 04-05, 2024

World Nursing Congress

Toronto, Canada
October 10-11, 2024

16th International Conference on Gynecology

Madrid, Spain
November 14-15, 2024

30th World Congress on Nursing and Healthcare

Tokyo, Japan
November 28-29, 2024

7th Annual Conference on Pediatric, Nursing and Healthcare

Bali, Indonesia
December 04-05, 2024

4th Global Summit on Nursing Practice

Orlando, USA

Clinical Trials -Breast Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in